Dr. Phil Boyd is a seasoned Chief Financial Officer with over 20 years of experience leading finance in private and public life science companies. Holding a PhD in Genetics from the University of Leeds, he has guided firms like Enterprise Therapeutics and Syntaxin Ltd through significant growth and acquisition. Colleagues describe him as intelligent, astute, and a pleasure to work with.
Phil maintains a strong connection to academia and industry advancement. His background includes an exchange scheme at Vanderbilt University and roles such as a Visiting Fellow, demonstrating a commitment to fostering collaboration between scientific research and commercial enterprise. He also serves as a Non-Executive Director for UK BioCentre, furthering industry development.
He has chaired the BioIndustry Associations Finance and Tax Advisory Committee, influencing key financial policy discussions within the UK life sciences sector.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.